The long-acting dopamine receptor agonist cabergoline in early Parkinson's disease: final results of a 5-year, double-blind, levodopa-controlled study (Q45031559)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The long-acting dopamine receptor agonist cabergoline in early Parkinson's disease: final results of a 5-year, double-blind, levodopa-controlled study |
scientific article |
Statements
1 reference
The long-acting dopamine receptor agonist cabergoline in early Parkinson's disease: final results of a 5-year, double-blind, levodopa-controlled study (English)
1 reference
Jean-Louis Montastruc
1 reference
Fulvio Bracco
1 reference
Angelo Battaglia
1 reference
Carlos Chouza
1 reference
Erik Dupont
1 reference
Oscar Gershanik
1 reference
Jose Felix Marti Masso
1 reference
PKDS009 Study Group
1 reference
1 January 2004
1 reference
1 reference
18
1 reference
11
1 reference
733-746
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference